Insider · CIK 0001554403

Nash Christine A

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001554403

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-13	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+28.5K sh	—	—	28,500
2024-05-15	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+16.5K sh	—	—	16,500
2023-05-17	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,490
2022-05-24	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+2,240 sh	—	—	2,240
2022-04-04	RLYBRallybio Corp · Option (Right to Buy)A Award	Director	AAward	+26.9K sh	—	—	26,880
2015-05-07	HYPERION THERAPEUTICS INCU Disposition from Tender	SVP & Chief Commercial Officer	UDisposition from Tender	−11.5K sh	$46.00	−$529K	0
2015-05-07	HYPERION THERAPEUTICS INCD Disposition to Issuer	SVP & Chief Commercial Officer	DDisposition to Issuer	−25.5K sh	$46.00	−$1.17M	0
2015-05-07	HYPERION THERAPEUTICS INCD Disposition to Issuer	SVP & Chief Commercial Officer	DDisposition to Issuer	−59.1K sh	$46.00	−$2.72M	0
2015-05-07	HYPERION THERAPEUTICS INCStock Option (Right to Buy)D Disposition to Issuer	SVP & Chief Commercial Officer	DDisposition to Issuer	−6,881 sh	$46.00	−$317K	0
2015-05-07	HYPERION THERAPEUTICS INCStock Option (Right to Buy)D Disposition to Issuer	SVP & Chief Commercial Officer	DDisposition to Issuer	−39.5K sh	$46.00	−$1.82M	0
2015-05-07	HYPERION THERAPEUTICS INCStock Option (Right to Buy)D Disposition to Issuer	SVP & Chief Commercial Officer	DDisposition to Issuer	−50K sh	$46.00	−$2.3M	0
2015-05-07	HYPERION THERAPEUTICS INCStock Option (Right to Buy)D Disposition to Issuer	SVP & Chief Commercial Officer	DDisposition to Issuer	−32.5K sh	$46.00	−$1.5M	0
2015-05-07	HYPERION THERAPEUTICS INCStock Option (Right to Buy)D Disposition to Issuer	SVP & Chief Commercial Officer	DDisposition to Issuer	−91 sh	—	—	0
2015-05-07	HYPERION THERAPEUTICS INCStock Option (Right to Buy)D Disposition to Issuer	SVP & Chief Commercial Officer	DDisposition to Issuer	−18 sh	—	—	0
2015-05-01	HYPERION THERAPEUTICS INCM Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	+16.2K sh	$1.28	+$20.7K	53,160
2015-05-01	HYPERION THERAPEUTICS INCM Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	+12.7K sh	$4.08	+$51.9K	65,869
2015-05-01	HYPERION THERAPEUTICS INCM Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	+30.2K sh	$7.31	+$221K	96,090
2015-05-01	HYPERION THERAPEUTICS INCEmployee Stock Option (right to buy)M Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	−16.2K sh	—	—	0
2015-05-01	HYPERION THERAPEUTICS INCEmployee Stock Option (right to buy)M Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	−12.7K sh	—	—	0
2015-05-01	HYPERION THERAPEUTICS INCEmployee Stock Option (right to buy)M Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	−30.2K sh	—	—	6,881
2015-03-17	HYPERION THERAPEUTICS INCM Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	+10K sh	$4.08	+$40.8K	29,003
2015-03-17	HYPERION THERAPEUTICS INCS Sale	SVP & Chief Commercial Officer	SSale	−10K sh	$37.56	−$376K	19,003
2015-03-17	HYPERION THERAPEUTICS INCStock Option (Right to Buy)M Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	−10K sh	—	—	12,709
2015-03-12	HYPERION THERAPEUTICS INCStock Option (Right to Buy)M Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	−10K sh	—	—	22,709
2015-03-10	HYPERION THERAPEUTICS INCS Sale	SVP & Chief Commercial Officer	SSale	−1,450 sh	$30.10	−$43.6K	19,003
2015-03-10	HYPERION THERAPEUTICS INCM Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	+10K sh	$4.08	+$40.8K	29,003
2015-03-10	HYPERION THERAPEUTICS INCS Sale	SVP & Chief Commercial Officer	SSale	−10K sh	$35.08	−$351K	19,003
2015-03-09	HYPERION THERAPEUTICS INCS Sale	SVP & Chief Commercial Officer	SSale	−5,650 sh	$29.32	−$166K	23,253
2015-03-09	HYPERION THERAPEUTICS INCS Sale	SVP & Chief Commercial Officer	SSale	−2,800 sh	$30.00	−$84K	20,453
2015-02-09	HYPERION THERAPEUTICS INCA Award	SVP & Chief Commercial Officer	AAward	+18K sh	—	—	46,903
2015-02-09	HYPERION THERAPEUTICS INCEmployee Stock Option (right to buy)A Award	SVP & Chief Commercial Officer	AAward	+32.5K sh	—	—	32,500
2015-01-20	HYPERION THERAPEUTICS INCS Sale	SVP & Chief Commercial Officer	SSale	−2,500 sh	$24.36	−$60.9K	31,403
2015-01-20	HYPERION THERAPEUTICS INCS Sale	SVP & Chief Commercial Officer	SSale	−2,500 sh	$25.27	−$63.2K	28,903
2015-01-02	HYPERION THERAPEUTICS INCF Tax Payment	SVP & Chief Commercial Officer	FTax Payment	−1,095 sh	$24.28	−$26.6K	33,903
2014-10-15	HYPERION THERAPEUTICS INCM Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	+10K sh	$1.28	+$12.8K	34,998
2014-10-15	HYPERION THERAPEUTICS INCStock Option (Right to Buy)M Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	−10K sh	—	—	16,157
2014-03-11	HYPERION THERAPEUTICS INCA Award	SVP & Chief Commercial Officer	AAward	+10K sh	—	—	24,998
2014-03-11	HYPERION THERAPEUTICS INCEmployee Stock Option (right to buy)A Award	SVP & Chief Commercial Officer	AAward	+50K sh	—	—	50,000
2014-03-06	HYPERION THERAPEUTICS INCM Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	+15K sh	$1.28	+$19.2K	20,098
2014-03-06	HYPERION THERAPEUTICS INCS Sale	SVP & Chief Commercial Officer	SSale	−5,000 sh	$29.03	−$145K	15,098
2014-03-06	HYPERION THERAPEUTICS INCS Sale	SVP & Chief Commercial Officer	SSale	−100 sh	$30.05	−$3,005	14,998
2014-03-06	HYPERION THERAPEUTICS INCStock Option (right to buy)M Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	−15K sh	—	—	26,157
2014-01-14	HYPERION THERAPEUTICS INCM Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	+6,100 sh	$1.28	+$7,808	6,198
2014-01-14	HYPERION THERAPEUTICS INCS Sale	SVP & Chief Commercial Officer	SSale	−1,100 sh	$24.01	−$26.4K	5,098
2014-01-14	HYPERION THERAPEUTICS INCStock Option (right to buy)M Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	−6,100 sh	—	—	41,157
2014-01-10	HYPERION THERAPEUTICS INCM Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	+8,900 sh	$1.28	+$11.4K	8,998
2014-01-10	HYPERION THERAPEUTICS INCS Sale	SVP & Chief Commercial Officer	SSale	−8,900 sh	$24.10	−$214K	98
2014-01-10	HYPERION THERAPEUTICS INCStock Option (right to buy)M Exercise/Conversion	SVP & Chief Commercial Officer	MExercise/Conversion	−8,900 sh	—	—	47,257
2013-04-15	HYPERION THERAPEUTICS INCStock Option (right to buy)A Award	SVP & Chief Commercial Officer	AAward	+39.5K sh	—	—	39,500
2012-07-31	HYPERION THERAPEUTICS INCC Conversion	SVP & Chief Commercial Officer	CConversion	+97 sh	—	—	98

Recent filings

Accepted (ET)
May 154
Nash Christine A0001739410-25-000084
SEC(opens sec.gov)
May 174
Nash Christine A0001739410-24-000089
SEC(opens sec.gov)
May 194
Nash Christine A0000899243-23-013406
SEC(opens sec.gov)
May 264
Nash Christine A0000899243-22-019828
SEC(opens sec.gov)
Apr 64
Nash Christine A0000899243-22-014169
SEC(opens sec.gov)
May 84
HYPERION THERAPEUTICS INC0001209191-15-040802
SEC(opens sec.gov)
May 54
HYPERION THERAPEUTICS INC0001437749-15-009010
SEC(opens sec.gov)

Companies

Address

C/O HYPERION THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 200

SOUTH SAN FRANCISCO, CA, 94080